AHG vs LX

For growth investors, Akso Health Group (AHG) is the stronger pick with 512.

1% revenue growth year-over-year, versus 8. 8% for LexinFintech Holdings Ltd. (LX). LexinFintech Holdings Ltd. (LX) offers the better valuation at 2. 2x trailing P/E (0. 3x forward), making it the more compelling value choice. Analysts rate LexinFintech Holdings Ltd. (LX) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, LexinFintech Holdings Ltd.

is actually cheaper at 0. 3x.

Over the past 5 years, Akso Health Group (AHG) delivered a total return of +42.

4%, compared to -66. 4% for LexinFintech Holdings Ltd. (LX). Over 10 years, the gap is even starker: LX returned -74. 1% versus AHG's -97. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Akso Health Group (AHG) is the lower-risk stock at 0.

14β versus LexinFintech Holdings Ltd. 's 1. 25β — meaning LX is approximately 777% more volatile than AHG relative to the S&P 500. On balance sheet safety, Akso Health Group (AHG) carries a lower debt/equity ratio of 0% versus 49% for LexinFintech Holdings Ltd. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Akso Health Group (AHG) is pulling ahead at 512.

1% versus 8. 8% for LexinFintech Holdings Ltd. (LX). On earnings-per-share growth, the picture is similar: LexinFintech Holdings Ltd. grew EPS 2. 5% year-over-year, compared to -23. 1% for Akso Health Group. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

LexinFintech Holdings Ltd.

(LX) is the more profitable company, earning 7. 7% net margin versus -913. 4% for Akso Health Group — meaning it keeps 7. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LX leads at 16. 1% versus -1125. 4% for AHG. At the gross margin level — before operating expenses — LX leads at 35. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, LexinFintech Holdings Ltd.

(LX) trades at 0. 3x forward P/E versus 0. 5x for Akso Health Group — 0. 2x cheaper on a one-year earnings basis.

In this comparison, LX (6.

9% yield) pays a dividend. AHG does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Akso Health Group (AHG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

14)). Both have compounded well over 10 years (AHG: -97. 1%, LX: -74. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: AHG is a small-cap high-growth stock; LX is a small-cap deep-value stock. LX pays a dividend while AHG does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.